Complete genome sequence of Acinetobacter baumannii XH386 (ST208), a multi-drug resistant bacteria isolated from pediatric hospital in China

Genomics Data

Volumn 7, Issue , 2016, Pages 269-274

  Fang, Youhong ^a   Quan, Jingjing ^b   Hua, Xiaoting ^b   Feng, Ye ^a   Li, Xi ^b   Wang, Jianfeng ^b   Ruan, Zhi ^b   Shang, Shiqiang ^a   Yu, Yunsong ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Acinetobacter baumannii; Multi drug resistance; Paediatric

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM; CARBAPENEM; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIUM ISOLATION; GENE SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEDIATRIC HOSPITAL; PHENOTYPE; PHYLOGENOMICS; PRIORITY JOURNAL;

EID: 84957802304     PISSN: 22135960     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gdata.2015.12.002     Document Type: Article

References (12)

1. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N. Engl. J. Med. 2008, 358(12):1271-1281.
2. Peleg A.Y., Paterson D.L. Multidrug-resistant Acinetobacter: a threat to the antibiotic era. Intern. Med. J. 2006, 36(8):479-482.
3. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 2007, 5(12):939-951.
4. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect. Dis. 2008, 8(12):751-762.
5. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 2008, 21(3):538-582.
6. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 2006, 12(9):826-836.
7. Richet H.M., Mohammed J., McDonald L.C., Jarvis W.R. Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg. Infect. Dis. 2001, 7(2):319-322.
8. Hsu A.J., Tamma P.D. Treatment of multidrug-resistant Gram-negative infections in children. Clin. Infect. Dis. 2014, 58(10):1439-1448.
9. Adams-Haduch J.M., Onuoha E.O., Bogdanovich T., Tian G.B., Marschall J., Urban C.M., Spellberg B.J., Rhee D., Halstead D.C., Pasculle A.W., Doi Y. Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States. J. Clin. Microbiol. 2011, 49(11):3849-3854.
10. Wang X., Qiao F., Yu R., Gao Y., Zong Z. Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study. BMC Microbiol. 2013, 13:234.
11. Deng M., Zhu M.H., Li J.J., Bi S., Sheng Z.K., Hu F.S., Zhang J.J., Chen W., Xue X.W., Sheng J.F., Li L.J. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese University Hospital. Antimicrob. Agents Chemother. 2014, 58(1):297-303.
12. Wen H., Wang K., Liu Y., Tay M., Lauro F.M., Huang H., Wu H., Liang H., Ding Y., Givskov M., Chen Y., Yang L. Population dynamics of an Acinetobacter baumannii clonal complex during colonization of patients. J. Clin. Microbiol. 2014, 52(9):3200-3208.